Cisen Pharmaceutical Co., Ltd. (603367.SS)

15.88 -0.20 (-1.24%) At close: 03:00PM CST

Cisen Pharmaceutical Co., Ltd.

No. 16 Tongji Road
High-tech Zone
Jining 272073
China
86 53 7298 9199
https://www.lkcisen.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 3,402

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Zhenxin Du	Chairman, GM & CFO	N/A	N/A	1967
Ms. Xiu Lian Lu	Deputy GM & Director	N/A	N/A	1967
Mr. Liushan Hao	Deputy GM & Director	N/A	N/A	1970

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells chemical drug preparations and health care products in China and internationally. The company's chemical drug preparations include liver disease drugs, antitumor and auxiliary drugs, nutrition preparations, contrast agents, antibiotics, digestive system agents, polypropylene ampoules, and external preparations, as well as sedation anesthesia, cardiovascular, cough and asthma, immunomodulator, infusion, and therapeutic infusion products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd. and changed its name to Cisen Pharmaceutical Co., Ltd. in 2011. Cisen Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Jining, the People's Republic of China.

Corporate governance

Cisen Pharmaceutical Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.